Bone Marrow Failure in Children With Acute Liver Failure

作者: John Tung , Nedim Hadzic , Mark Layton , Alastair J. Baker , Anil Dhawan

DOI: 10.1097/00005176-200011000-00019

关键词:

摘要: Background Aplastic anemia is a rare but well-recognized complication of acute hepatitis and liver failure. The cause unknown, the condition fatal without bone marrow recovery. Treatment includes immunosuppression regimens or transplantation. purpose this study was to investigate incidence, cause, treatment, outcomes disorder in children. Methods Retrospective chart review 75 patients with failure major pediatric center. Results Eight had evidence Of those, six aplastic anemia, two transient suppression. There were five boys, median age 57 months (range, 36-132 months). Two parvovirus B19, non-A, non-B, non-C hepatitis. Five underwent transplantation: auxiliary one, orthotopic four. interval between initial symptoms development and/or suppression 21 99 days (median, 39 days). Four received intravenous antithymocyte globulin (ATG) antilymphocyte (ALG). Median recovery period granulopoiesis 62 27-115 made full recovery, one myelodysplasia, unresponsive disease died septic complications. did not receive ATG/ALG, Three transplantation, all four resumed granulopoiesis. One child who transplantation sepsis chronic rejection. 20-153 Conclusions Bone occurs 10.7% children It sometimes association B19 infection. ATG/ALG successful well tolerated most cases.

参考文章(35)
Bruce M. Camitta, David G. Nathan, Edwin N. Forman, Robertson Parkman, Joel M. Rappeport, Tessa D. Orellana, Posthepatitic Severe Aplastic Anemia—An Indication for Early Bone Marrow Transplantation Blood. ,vol. 43, pp. 473- 483 ,(1974) , 10.1182/BLOOD.V43.4.473.473
B. Cohen, Parvovirus B19: an expanding spectrum of disease. BMJ. ,vol. 311, pp. 1549- 1552 ,(1995) , 10.1136/BMJ.311.7019.1549
A Bacigalupo, G Broccia, G Corda, W Arcese, M Carotenuto, A Gallamini, F Locatelli, PG Mori, P Saracco, G Todeschini, Antilymphocyte globulin, cyclosporin, and granulocyte colony- stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party Blood. ,vol. 85, pp. 1348- 1353 ,(1995) , 10.1182/BLOOD.V85.5.1348.BLOODJOURNAL8551348
NS Young, AJ Barrett, The Treatment of Severe Acquired Aplastic Anemia Blood. ,vol. 85, pp. 3367- 3377 ,(1995) , 10.1182/BLOOD.V85.12.3367.BLOODJOURNAL85123367
BM Camitta, ED Thomas, DG Nathan, RP Gale, KJ Kopecky, JM Rappeport, G Santos, EC Gordon-Smith, R Storb, A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia Blood. ,vol. 53, pp. 504- 514 ,(1979) , 10.1182/BLOOD.V53.3.504.504
John G. O'Grady, Graeme J.M. Alexander, Karen M. Hayllar, Roger Williams, Early indicators of prognosis in fulminant hepatic failure Gastroenterology. ,vol. 97, pp. 439- 445 ,(1989) , 10.1016/0016-5085(89)90081-4
N. Hadzic, M. Layton, N. D. Heaton, M. Rela, A. J. Baker, G. Mieli-Vergani, Anti-thymocyte globulin, cyclosporin A and granulocyte colony-stimulating factor for severe aplastic anaemia complicating paediatric liver transplantation. European Journal of Pediatrics. ,vol. 157, pp. 107- 108 ,(1998) , 10.1007/S004310050779
A. Bacigalupo, M. Chaple, J. Hows, M. T. Lint, S. McCann, D. Milligan, J. Chessells, A. H. Goldstone, J. Ottolander, E. Th. Veer, B. Comotti, P. Coser, G. Broccia, A. Bosi, A. Locasciulli, L. Catalano, R. Battista, W. Arcese, M. Carotenuto, A. M. Marmont, E. C. Gordon Smith, Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: A randomized trial from the EBMT SAA working party British Journal of Haematology. ,vol. 83, pp. 145- 151 ,(1993) , 10.1111/J.1365-2141.1993.TB04645.X